InvestorsHub Logo

inveterate

06/07/22 9:39 PM

#484314 RE: GPha #484285

Thank you, GPha, for your kind reply. The nomenclature explanation was particularly helpful. So I am assuming that the cancer treatment with "Dostarlimab" refers to an agent targeting the immune system. On first reading of the article I posted I was concerned that we had a true competitor for NWBO, but upon further inquiry I realized that they were working with only a sample of 18 patients who had been specifically chosen.
Thank you again for your thoughtful reply and welcome explanation.

ATLnsider

06/07/22 10:09 PM

#484319 RE: GPha #484285

Thanks for sharing that knowledge GPha

vator

06/09/22 2:37 AM

#484799 RE: GPha #484285

Useful information.